Home / Business and Economy / Apollo Nears $20B J&J Ortho Unit Deal
Apollo Nears $20B J&J Ortho Unit Deal
12 Sep
Summary
- Apollo Global Management is nearing a deal for J&J's orthopedics unit.
- The acquisition could be valued at nearly $20 billion.
- J&J aims to focus on higher-growth healthcare segments by separating the unit.
Apollo Global Management is reportedly in advanced discussions to acquire Johnson & Johnson's orthopedics business. The potential transaction is valued at approximately $20 billion. Several private equity firms have also expressed interest in acquiring the unit.
Johnson & Johnson announced last year its intention to separate its orthopedics unit, DePuy Synthes, into a distinct company. This strategic move aims to sharpen J&J's focus on rapidly expanding healthcare segments.
The J&J orthopedics division specializes in manufacturing hip, knee, and shoulder implants, alongside surgical instruments. In 2025, this unit recorded sales totaling $9.3 billion.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
